Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2007-02-20
2007-02-20
Kwon, Brian (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S560000, C514S866000
Reexamination Certificate
active
10766118
ABSTRACT:
The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and/or prevention. A method of making a composition for the treatment or prevention of non-insulin dependent diabetes mellitus and related diseases comprising combining phytanic acid or derivatives thereof with a pharmaceutically acceptable additive or adjuvant, and a composition for the treatment or prevention of non-insulin dependent diabetes mellitus comprising phytanic acid or derivatives thereof are also provided.
REFERENCES:
patent: 4624966 (1986-11-01), Yamamoto et al.
patent: 6436993 (2002-08-01), Evans et al.
patent: 6552055 (2003-04-01), Spiegelman et al.
patent: 196 44 422 (1996-10-01), None
patent: WO 97/09039 (1997-03-01), None
Derwent English language abstract of JP 52 085125 (1977).
Derwent English language abstract of DE 196 44 422 (Document B2 above).
Lemotte et al., “Phytanic acid is a retinoid X receptor ligand,”Eur. J. Biochem., vol. 236, No. 1, pp. 328-333 (1996).
McCarty, M.F., “The chlorophyll metabolite phytanic acid is a natural rexinoid—potential for treatment and prevention of diabetes,”Medical Hypotheses, vol. 56, No. 2, pp. 217-219 (2001).
Mukherjee et al., “Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists,”Nature, vol. 386, No. 6623, pp. 407-410 (1997).
Van Den Branden et al., “Phytol and Peroxisome Proliferation,”Pediatric Research, vol. 20, No. 5, pp. 411-415 (1986).
C. Dreyer et al., “Control of the Peroxisomal β-Oxidation Pathway By A Novel Family Of Nuclear Hormone Receptors,”Cell, vol. 68, No. 5, pp. 879-887 (1992).
P. Ellinghaus et al., “Phytanic Acid Activates The Peroxisome Proliferator-activated Receptor α (PPARα) In Sterol Carrier Protein 2-/Sterol Carrier Protein x-deficient Mice,”J. Biol. Chem., vol. 274, No. 5, pp. 2766-2772 (1999).
S. Kitareewan et al., “Phytol Metabolites Are Circulating Dietary Factors That Activate The Nuclear Receptor RXR,”Mol. Biol. Cell, vol. 7, pp. 1153-1166 (1996).
J.M. Lehmann et al., “An Antidiabetic Thiazolidinedione Is A High Affinity Ligand For Peroxisome Proliferator-activated Receptor γ (PPARγ),”J. Biol. Chem., vol. 270, No. 22, pp. 12953-12956 (1995).
P.K. Lemotte et al., “Phytanic Acid Is A Retinoid X Receptor Ligand,”Eur. J. Biochem., vol. 236, pp. 328-333 (1996).
H. Vuorinen-Markhola et al., “Lowering Of Triglycerides By Gemfibrozil Affects Neither The Glucoregulatory Nor Antilipolytic Effect Of Insulin In Type 2 (Non-insulin-dependent) Diabetic Patients,”Diabetologia, vol. 36, pp. 161-169 (1993).
R. Mukherjee et al., “Sensitization Of Diabetic And Obese Mice To Insulin By Retinoid X Receptor Agonists,”Nature, vol. 386, No. 27, pp. 407-410 (1997).
C. Wolfrum et al., “Phytanic Acid Is Ligand And Transcriptional Activator Of Murine Liver Fatty Acid Binding Protein,”J. Lipid Res., vol. 40, pp. 708-714 (1999).
A.W. Zomer et al., “Pristanic Acid And Phytanic Acid: Naturally Occurring Ligands For The Nuclear Receptor Peroxisome Proliferator-activated Receptor α,”J. Lipid Res., vol. 41, pp. 1801-1807 (2000).
Fluehmann Beat
Heim Manuel
Hunziker Willi
Weber Peter
Bryan Cave LLP
DSm Nutritional Products, Inc.
Kwon Brian
LandOfFree
Method of treating non-insulin dependent diabetes mellitus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating non-insulin dependent diabetes mellitus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating non-insulin dependent diabetes mellitus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3823966